PT-141 10mg | 10-Vial Kit — Bremelanotide MC3R/MC4R agonist — activates hypothalamic melanocortin receptors to drive central sexual arousal independently of vascular mechanisms; FDA-approved mechanism for HSDD research. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
PT-141 10mg | 20-Vial Kit — Bremelanotide MC3R/MC4R agonist — activates hypothalamic melanocortin receptors to drive central sexual arousal independently of vascular mechanisms; FDA-approved mechanism for HSDD research. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
TB-500 10mg | 10-Vial Kit — Thymosin beta-4 C-terminal fragment — sequesters G-actin to regulate cell migration and angiogenesis; studied for wound healing, cardiac repair, and systemic anti-inflammatory research. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
TB-500 10mg | 20-Vial Kit — Thymosin beta-4 C-terminal fragment — sequesters G-actin to regulate cell migration and angiogenesis; studied for wound healing, cardiac repair, and systemic anti-inflammatory research. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
TB-500 20mg | 10-Vial Kit — Thymosin beta-4 C-terminal fragment — sequesters G-actin to regulate cell migration and angiogenesis; studied for wound healing, cardiac repair, and systemic anti-inflammatory research. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
TB-500 20mg | 20-Vial Kit — Thymosin beta-4 C-terminal fragment — sequesters G-actin to regulate cell migration and angiogenesis; studied for wound healing, cardiac repair, and systemic anti-inflammatory research. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
TB-500 2mg | 10-Vial Kit — Thymosin beta-4 C-terminal fragment — sequesters G-actin to regulate cell migration and angiogenesis; studied for wound healing, cardiac repair, and systemic anti-inflammatory research. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
TB-500 2mg | 20-Vial Kit — Thymosin beta-4 C-terminal fragment — sequesters G-actin to regulate cell migration and angiogenesis; studied for wound healing, cardiac repair, and systemic anti-inflammatory research. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
QSC TB-500 (Thymosin Beta-4 Fragment / Actin-Binding Recovery Peptide (Oral)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. 500mcg per tablet, 100-count. Research use only.
TB-500 5mg | 10-Vial Kit — Thymosin beta-4 C-terminal fragment — sequesters G-actin to regulate cell migration and angiogenesis; studied for wound healing, cardiac repair, and systemic anti-inflammatory research. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
TB-500 5mg | 20-Vial Kit — Thymosin beta-4 C-terminal fragment — sequesters G-actin to regulate cell migration and angiogenesis; studied for wound healing, cardiac repair, and systemic anti-inflammatory research. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
TB-500 Fragment 10mg | 10-Vial Kit | Active actin-binding fragment of Thymosin Beta-4 — promotes tissue repair, angiogenesis, and anti-inflammatory signalling. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
TB-500 Fragment 10mg | 10-Vial Kit | Active actin-binding fragment of Thymosin Beta-4 — promotes tissue repair, angiogenesis, and anti-inflammatory signalling. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Thymosin Alpha-1 2mg | 10-Vial Kit — Thymic immunomodulatory peptide (Thymalfasin, Tα1) — stimulates T-cell maturation, enhances NK cell function, and upregulates type I interferons; studied in immune deficiency, chronic viral, and cancer adjuvant models. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Thymosin Alpha-1 2mg | 20-Vial Kit — Thymic immunomodulatory peptide (Thymalfasin, Tα1) — stimulates T-cell maturation, enhances NK cell function, and upregulates type I interferons; studied in immune deficiency, chronic viral, and cancer adjuvant models. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
VIP 10mg | 10-Vial Kit — Vasoactive intestinal peptide — VPAC1/VPAC2 receptor-mediated neuropeptide studied for bronchodilation, immunomodulation, circadian rhythm regulation via SCN, and anti-inflammatory effects in GI and pulmonary research. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.